ECORECORHealthcare · Medical Devices

ECOR Stock Forecast: electroCore, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$4.42
−8.87% on the day

The median 12-month analyst price target for electroCore, Inc. is $18. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 75 of 100 as at 21 Nov 2026 — inside the top quartile.

Market cap
$44.7M
Ticker Nerd rank
75/ 100
Median analyst target
$18
Analysts covering
5
Revenue$9.4M+28.0% y/y
Operating income−$2.8M
Net income−$3.1M
Free cash flow−$3.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−15.8%
1M
−41.0%
YTD
−1.4%
1Y
−3.7%
From 52W high
−64.0%
From 52W low
0.0%
$4
$12
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores electroCore, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
75/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
89
Revisions
76
Issuance
63
Quality
56
Momentum
55
Accruals
43
Value
40
Volatility
18

Growth (89): Sales and profits are climbing, and climbing faster than before.

Volatility (18): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

ECOR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ECOR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15$20$25Jan 26Apr 26Jul 26Oct 26ECORHigh $26Median $18Low $12

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says5 analysts
5
Buy
0
Hold
0
Sell
$12
Low
$18
Median
$26
High
Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
26 Jan 2026HC Wainwright & Co.MaintainsBuy$25 → $18
13 Mar 2025HC Wainwright & Co.ReiteratesBuy—
13 Mar 2025Ladenburg ThalmannMaintainsBuy—
18 Dec 2024HC Wainwright & Co.MaintainsBuy—
14 Mar 2024HC Wainwright & Co.ReiteratesBuy—
22 Jan 2024HC Wainwright & Co.MaintainsBuy—
9 Nov 2023HC Wainwright & Co.MaintainsBuy—
10 Aug 2023HC Wainwright & Co.ReiteratesBuy—
4 May 2023HC Wainwright & Co.MaintainsBuy—
18 Apr 2023CG CapitalReiteratesOutperform—
18 Apr 2023HC Wainwright & Co.MaintainsBuy—
9 Mar 2023HC Wainwright & Co.ReiteratesBuy—
13 Jan 2023Brookline CapitalInitiatesBuy$1.25
19 Jan 2022HC Wainwright & Co.MaintainsBuy$3.00 → $2.75
27 July 2021Ladenburg ThalmannInitiatesBuy—
23 Oct 2020Brookline CapitalInitiatesBuy—
30 Sept 2020Maxim GroupInitiatesBuy—
14 Aug 2020BTIGUpgradeBuy—
14 Aug 2020HC Wainwright & Co.MaintainsBuy$2.50 → $3.00
24 Mar 2020Cantor FitzgeraldMaintainsNeutral$4.00 → $2.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ECOR.

Market Radar

This page is one stock. Monday covers all of them.

ECOR appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

ECOR vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, electroCore, Inc. returned −3.7% against +6.9% for the S&P 500, dividends included.

ECOR vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200250Jan 26Apr 26Jul 26Oct 26ECORS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ECOR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
1.2×

Cheaper than 61% of US stocks

Price / book
—
EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
86.5%

Higher than 95% of US stocks

Operating margin
−33.1%

Higher than 20% of US stocks

Net margin
—
Returns & dividend
Return on equity
—
Return on assets
−40.7%

Higher than 10% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • electroCore, Inc. has a market value of $44.7M and an enterprise value of $46.9M.

  • Revenue in the twelve months to 30 June 2026: $37.0M. The latest quarter grew 28.0% year on year.

  • Net income over the same four quarters: −$14.8M, a −40.0% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$9.7M.

  • Shares outstanding: 9.0M.

  • electroCore, Inc. employs 83 people — $445K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Nov 2026

Data provided by Twelve Data

Peers

ECOR and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
ECORelectroCore, Inc.$44.7M75
ELUTElutia, Inc.$39.9M30
SRTSSensus Healthcare, Inc.$37.2M50
RPIDRapid Micro Biosystems, Inc.$36.6M36
MBOTMicrobot Medical, Inc.$45.7M15
MDAISpectral AI, Inc.$33.5M26
MYOMyomo, Inc.$32.1M62

Take a look at ECOR’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own electroCore, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about ECOR

What is the ECOR stock price forecast for 2026-2027?

The median 12-month analyst price target for electroCore, Inc. is $18, with estimates ranging from $12 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ECOR stock a buy right now?

Of the 5 analysts covering electroCore, Inc., 5 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks electroCore, Inc. 75 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ECOR?

As at 21 Nov 2026, electroCore, Inc. ranks 75 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (89 of 100).

Will ECOR stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts is $18, and Ticker Nerd's factor model ranks electroCore, Inc. 75 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ECOR stock forecast for 2030?

No analyst covering electroCore, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ECOR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $12 to $26 over the next 12 months.

How has ECOR stock performed over the past year?

electroCore, Inc. returned -3.7% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does electroCore, Inc. do?

electroCore, Inc. is a commercial-stage bioelectronic medicine company that develops non-invasive vagus nerve stimulation (nVNS) products for healthcare and wellness use. Its core offerings include gammaCore, a prescription handheld device used for primary headache conditions such as migraine and cluster headache, as well as Quell Fibromyalgia for chronic pain management.

Company

About electroCore, Inc.

electroCore, Inc. is a commercial-stage bioelectronic medicine company that develops non-invasive vagus nerve stimulation (nVNS) products for healthcare and wellness use. Its core offerings include gammaCore, a prescription handheld device used for primary headache conditions such as migraine and cluster headache, as well as Quell Fibromyalgia for chronic pain management. The company also markets Truvaga and TAC-STIM, consumer-focused nVNS products designed to support general wellness and human performance. electroCore’s technology platform is built around non-invasive neuromodulation, with products intended for both clinical and personal use across the United States, the United Kingdom, and international markets. Headquartered in Rockaway, New Jersey, electroCore serves a growing role in the medical device and bioelectronic therapy sectors by offering portable, non-surgical alternatives that address pain, wellness, and performance-related needs.

CEO Mr. Joshua S. Lev · 83 employees · United States · https://www.electrocore.com